retatrutide safety retatrutide clinical trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide UK 2026: Phase 3
Description
(2024, February)
These findings show that GLP-1s may hold promise as an adjunct therapy to insulin to reduce cardiovascular and kidney disease among individuals with T1D
How to take it: Inject on the same day each week, at any time of day, in your abdomen, thigh, or upper arm
Osmotic laxatives such as macrogol (polyethylene glycol) are often considered first-line for chronic constipation on GLP-1 therapy, as they draw water into the bowel to soften stools
It doesn't outperform injectables on raw weight loss numbers, but it removes a massive barrier for a large segment of the population
Contact an experienced Edwardsville nursing home abuse attorney from TorHoerman Law today for a free consultation to discuss your legal options
